当稀有性与胸部癌症相遇时:来自ITMIG 2024的叙事评论
Margaret Ottaviano1, Paolo Antonio Ascierto1, Erica Pietroluongo2
1Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy.
Mediastinum (Hong Kong, China)
|October 16, 2025
概括
由于其发病率低,罕见的胸部癌症 (RTC) 存在诊断和治疗方面的挑战. 本综述研究了SMARCA4缺乏的瘤,胸膜神经内分泌新生瘤和中胚芽细胞瘤,以改善RTC管理.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 病理学 病理学 病理学
背景情况:
- 罕见的胸部癌症 (RTCs) 是一种具有低发病率的多样化的恶性瘤群.
- 它们的稀有性导致诊断延迟,非标准化治疗和有限的临床试验.
- 分散的专业知识需要集中,多学科的管理和国际合作.
研究的目的:
- 提供三种代表性的RTC模型的概述:SMARCA4缺乏的未分化瘤,胸膜神经内分泌新生瘤和中胚芽细胞瘤.
- 突出这些罕见实体独特的临床,病理和治疗特征.
- 讨论优化RTC患者临床护理的策略.
主要方法:
- 使用PubMed,MEDLINE和会议记录进行了叙事审查,直到2025年1月.
- 搜索的重点是特定的罕见胸部癌症,包括SMARCA4缺陷的未分化瘤,胸膜神经内分泌新生瘤和中胚芽细胞瘤.
- 符合条件的来源包括英语出版的案例报告,回顾系列和叙事评论.
主要成果:
- 缺少SMARCA4的瘤代表了通过分子分析新定义的实体.
- 胸膜神经内分泌瘤是极为罕见的,并且具有生物攻击性.
- 中原生殖细胞瘤与淋巴体对应细胞具有共同的特征,但具有不同的临床行为.
- 在RTC管理中的常见主题包括诊断不确定性,有限的治疗选择和新兴的治疗方向.
结论:
- 目前对RTC的证据存在局限性.
- 未来的前景包括通过专门的注册表来提高结果.
- 量身定制的治疗策略对于改善罕见胸部癌症患者的治疗结果至关重要.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.9K
07:30Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
Published on: May 4, 2022
3.7K
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.